| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 成品药(元) | 94,155,079.91 | 184,401,472.65 | 95,685,214.04 | 220,017,289.35 |
| 原料药及中间体(元) | 713,347,322.61 | 1,468,343,420.64 | 699,658,986.44 | 1,140,661,346.06 |
| 贸易产品(元) | - | 36,001,134.50 | 22,520,348.20 | 111,391,211.30 |
| 原料药及中间体贸易(元) | 17,023,836.02 | - | - | - |
| 营业成本(元) | ||||
| 成品药(元) | 17,296,904.67 | 31,115,227.75 | 13,366,514.09 | 33,635,889.75 |
| 原料药及中间体(元) | 338,607,537.36 | 619,449,693.36 | 295,371,449.77 | 484,197,805.11 |
| 贸易产品(元) | - | 30,622,839.26 | 18,762,810.40 | 91,986,955.19 |
| 原料药及中间体贸易(元) | 16,477,652.02 | - | - | - |
| 毛利(元) | ||||
| 成品药(元) | 76,858,175.24 | 153,286,244.90 | 82,318,699.95 | 186,381,399.60 |
| 原料药及中间体(元) | 374,739,785.25 | 848,893,727.28 | 404,287,536.67 | 656,463,540.95 |
| 贸易产品(元) | - | 5,378,295.24 | 3,757,537.80 | 19,404,256.11 |
| 原料药及中间体贸易(元) | 546,184.00 | - | - | - |
| 毛利率(%) | ||||
| 成品药(%) | 81.63 | 83.13 | 86.03 | 84.71 |
| 原料药及中间体(%) | 52.53 | 57.81 | 57.78 | 57.55 |
| 贸易产品(%) | - | 14.94 | 16.69 | 17.42 |
| 原料药及中间体贸易(%) | 3.21 | - | - | - |
| 收入构成(%) | ||||
| 成品药(%) | 11.42 | 10.92 | 11.70 | 14.95 |
| 原料药及中间体(%) | 86.52 | 86.95 | 85.55 | 77.49 |
| 贸易产品(%) | - | 2.13 | 2.75 | 7.57 |
| 原料药及中间体贸易(%) | 2.06 | - | - | - |
| 毛利构成(%) | ||||
| 成品药(%) | 17.00 | 15.21 | 16.79 | 21.62 |
| 原料药及中间体(%) | 82.88 | 84.25 | 82.45 | 76.13 |
| 贸易产品(%) | - | 0.53 | 0.77 | 2.25 |
| 原料药及中间体贸易(%) | 0.12 | - | - | - |